About Glaucoma secondary to spherophakia/ectopia lentis and megalocornea
Glaucoma secondary to spherophakia/ectopia lentis and megalocornea is a rare disease catalogued by Orphanet (ORPHA:238763). It is associated with the LTBP2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Glaucoma secondary to spherophakia/ectopia lentis and megalocornea trials.
Search ClinicalTrials.gov for "Glaucoma secondary to spherophakia/ectopia lentis and megalocornea" or filter by Orphanet code ORPHA:238763 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Glaucoma secondary to spherophakia/ectopia lentis and megalocornea trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Glaucoma secondary to spherophakia/ectopia lentis and megalocornea. Updated daily.